Michael J. Dattoli, MD, is a board-certified radiation oncologist with well over two decades of brachytherapy experience and has performed thousands of prostate implant procedures. He is considered the foremost pioneer optimizing brachytherapy designs to maximize tumor eradication and minimize symptoms. Dr. Dattoli has successfully applied the same technology to other forms of cancer, including breast, head and neck, GI, GYN, sarcomas and lung malignancies. He is a noted author and speaker in this complex field of medicine. Dr. Dattoli attended the University of California at Berkeley and was the Valedictorian of his class at Vassar College; he earned his medical degree at Mount Sinai School of Medicine, Radiation Oncology at New York University Medical Center, then distinguished himself at Memorial Sloan-Kettering Cancer Center and New York Hospital-Cornell University Medical Center, as the Special Fellow in Brachytherapy. He was appointed Associate Professor in Brachytherapy and Radiation Oncology at Memorial Sloan- Kettering Cancer Center in New York and at New York Hospital-Cornell University Medical Center prior to relocating to Florida. Dr. Dattoli serves on multiple journal editorial review boards. Government appointments include “The Prostate Cancer Task Force” in Florida and consultant to the “Washington Oncology Roundtable Advisory Committee”. He was selected by the International Association of Oncologists as a Leading Physician of the World and top Brachytherapist.
Joseph M. Kaminski, MD, previously Senior Medical Staff at the National Cancer Institute at the National Institutes of Health, is a board certified Radiation Oncologist who is internationally known for his work in accelerating the development of cancer therapeutics including normal tissue radioprotectors/mitigators, imaging techniques, and important interventional devices. He has authored more than 70 publications in peer reviewed journals and has served on multiple journal editorial boards. Dr. Kaminski has also held positions as a Lead Medical Officer at the Food and Drug Administration and a medical officer at the National Institutes of Allergy and Infectious Diseases. He graduated with highest honors from Georgia Institute of Technology, one of the nation’s top bioengineering universities, and completed medical school at the Medical College of Georgia. Dr. Kaminski was a resident in Nuclear Medicine and Radiation Oncology at Vanderbilt University Medical Center (Nashville, TN), and also in Radiation Oncology at the prestigious Fox Chase Cancer Center (Philadelphia, PA). He comes to the Sarasota Center from his recent post at Georgia Regents University where he served as the Co-Leader of the Neurological Oncology Multidisciplinary Program for the Cancer Center and the Director of Genitourinary (e.g., prostate), Gastrointestinal, and Central Nervous System Radiation Programs.
As part of our endocrinology program (hormones and bone integrity), we call upon our world renowned consultant Jeffrey I. Mechanick, MD, FACP, FACE, FACN, ECNU, who is Clinical Professor of Medicine, Chief of Metabolic Support in the Division of Endocrinology, Diabetes and Bone Metabolism, Icahn School of Medicine at the Mount Sinai Hospital in New York City.
The Dattoli Cancer Center’s physicists, Drs. Shafiq Islam and Joseph Ting are key members of the patient treatment team. The physicists’ function is to verify by exacting calculations that the dose plan for daily radiation is appropriate, adequate and accurate for each individual patient, as well as to certify the minute calibrations of our linear accelerators that ultimately create and project the radiation doses into the patient. They work in close partnership with the physicians and the dosimetry design team. Drs. Islam and Ting have unparalleled expertise in the Varian systems employed at Dattoli Cancer Center. They provide direction for the Center’s important quality assurance standards.